International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 369-374 doi: 10.5281/zenodo.16744504
Original Article
Bacteriological Profile and Antibiogram of Blood Culture Isolates In Pediatric Population From A Tertiary Care Hospital: A Hospital-Based Observational Study
 ,
 ,
 ,
 ,
Published
Aug. 5, 2025
Abstract

Background: One of the main causes of illness and mortality in pediatric populations, especially in developing nations, is blood stream infections (BSIs). To enhance treatment results, it is essential to promptly identify the pathogenic organisms and the patterns of antibiotic resistance they exhibit.

Objective: To assess the antibiogram and bacteriological profile of blood culture isolates in children at a north Indian tertiary care facility.

Methods: 200 children with suspected BSIs, ages 0 to 18, participated in this 18-month hospital-based observational study. Antimicrobial susceptibility testing was carried out in accordance with CLSI guidelines, and blood cultures were processed using normal microbiological procedures.

Results: Pseudomonas aeruginosa, E.coli, and Klebsiella were the most common gram-negative bacteria among the isolates. Among gram positive Staphylococcus aures and Coagulase negative staphylococci (CoNS) were isolated. A significant prevalence of antimicrobial resistance was observed, particularly among Gram-negative isolates, with high resistance to cephalosporins and carbapenems. MRSA strains showed resistance to multiple agents but remained susceptible to vancomycin and linezolid. MRSA strains showed resistance to multiple agents but remained susceptible to vancomycin and linezolid.

Conclusion: The result shows the urgent need for local surveillance of antimicrobial resistance patterns in pediatric BSIs. To enhance clinical results and prevent the emergence of resistance, empirical antibiotic regimens need to be modified often to reflect local resistance trends.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1402 Views
240 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved